Across TCGA pan-cancer cohorts, MIR1233-1 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated MIR1233-1 data layer.
The strongest signal is observed in glioblastoma multiforme (GBM), where higher MIR1233-1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR1233-1 expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.
GBM are the cancer types where MIR1233-1 RNA most reproducibly stratifies survival.